Dabigatran: A new oral anticoagulant
Dabigatran, a direct thrombin inhibitor (DTI), has been approved as a new orally administrated anticoagulant in many countries including Thailand. Food and drug administration (FDA) Thailand has approved 75, 110 and 150 mg of dabigatran since 2009 for prevention of stroke and venous thromboembolism...
Saved in:
Main Authors: | Sirada Srihirun, สิรดา ศรีหิรัญ, Nathawut Sibmooh, ณัฐวุธ สิบหมู่ |
---|---|
Format: | Article |
Language: | English |
Published: |
2015
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/1103 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Language: | English |
Similar Items
-
Higher persistence in newly diagnosed nonvalvular atrial fibrillation patients treated with dabigatran versus warfarin
by: Zalesak, M., et al.
Published: (2014) -
NOVEL ANTICOAGULANTS FROM HEMATOPHAGOUS ANIMALS
by: IYER JANAKI KRISHNAMOORTHY
Published: (2015) -
Oral health literacy among mothers of pre-school children.
by: Tippanart Vichayanrat, et al.
Published: (2015) -
The East Asian Paradox: An Updated Position Statement on the Challenges to the Current Antithrombotic Strategy in Patients with Cardiovascular Disease
by: Kim, HK, et al.
Published: (2021) -
Dental caries and oral hygiene status among 6-8 years old schoolchildren in Hanoi and Langson cities, Vietnam.
by: Yaowaluk Ngeonwiwatkul, et al.
Published: (2014)